Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) had its price target dropped by HC Wainwright from $22.00 to $12.00 in a note issued to investors on Friday,Benzinga reports. The brokerage ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our ...

Affirm expanded its credit reporting to Experian to include all pay-over-time products. Consumers' credit scores will not be impacted by the new reporting policy, at least not initially. With ...

SAN FRANCISCO, March 19, 2025--(BUSINESS WIRE)--Affirm Holdings, Inc. (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, today announced it is expanding ...

It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...

Affirm Holdings (NASDAQ:AFRM) stock slumped 4.2% on Monday. The stock dropped 8.5% late Tuesday morning. However, BofA Securities analyst Jason Kupferberg calls the stock decline "overdone." ...

Affirm loses exclusive Walmart loan partnership to Klarna. Goldman Sachs lowers Affirm's price target following Walmart shift. With stocks plunging, steady income is key. Tim Melvin & Ryan Faloona ...

The partnership with Walmart is one that rival Affirm had previously owned. Klarna will provide the loans to Walmart customers through OnePay, a fintech startup in which it owns a majority stake ...